Sixth Merck Serono spin-off company to focus on gastrointestinal immunological disorders
05-Mar-2013
- Switzerland
The company is founded by Drs. Yolande Chvatchko and Alain Vicari, two seasoned immunologists with experience in team management and drug discovery expertise.
Most read news
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.